Journal article
A Randomized Trial of Adenotonsillectomy for Childhood Sleep Apnea
The New England journal of medicine, v 368(25), pp 2366-2376
20 Jun 2013
PMID: 23692173
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
BACKGROUND
Adenotonsillectomy is commonly performed in children with the obstructive sleep apnea syndrome, yet its usefulness in reducing symptoms and improving cognition, behavior, quality of life, and polysomnographic findings has not been rigorously evaluated. We hypothesized that, in children with the obstructive sleep apnea syndrome without prolonged oxyhemoglobin desaturation, early adenotonsillectomy, as compared with watchful waiting with supportive care, would result in improved outcomes.
METHODS
We randomly assigned 464 children, 5 to 9 years of age, with the obstructive sleep apnea syndrome to early adenotonsillectomy or a strategy of watchful waiting. Polysomnographic, cognitive, behavioral, and health outcomes were assessed at baseline and at 7 months.
RESULTS
The average baseline value for the primary outcome, the attention and executive-function score on the Developmental Neuropsychological Assessment (with scores ranging from 50 to 150 and higher scores indicating better functioning), was close to the population mean of 100, and the change from baseline to follow-up did not differ significantly according to study group (mean [+/- SD] improvement, 7.1 +/- 13.9 in the early-adenotonsillectomy group and 5.1 +/- 13.4 in the watchful-waiting group; P = 0.16). In contrast, there were significantly greater improvements in behavioral, quality-of-life, and polysomnographic findings and significantly greater reduction in symptoms in the early-adenotonsillectomy group than in the watchful-waiting group. Normalization of polysomnographic findings was observed in a larger proportion of children in the early-adenotonsillectomy group than in the watchful-aiting group (79% vs. 46%).
CONCLUSIONS
As compared with a strategy of watchful waiting, surgical treatment for the obstructive sleep apnea syndrome in school-age children did not significantly improve attention or executive function as measured by neuropsychological testing but did reduce symptoms and improve secondary outcomes of behavior, quality of life, and polysomnographic findings, thus providing evidence of beneficial effects of early adenotonsillectomy.
Metrics
Details
- Title
- A Randomized Trial of Adenotonsillectomy for Childhood Sleep Apnea
- Creators
- Carole L. Marcus - University of PennsylvaniaRenee H. Moore - North Carolina State UniversityCarol L. Rosen - Case Western Reserve UniversityBruno Giordani - University of MichiganSusan L. Garetz - University of MichiganGerry TaylorRon B. Mitchell - The University of Texas Southwestern Medical CenterRaouf Amin - Cincinnati Children's Hospital Medical CenterEliot S. Katz - Harvard University PressRaanan Arens - Yeshiva UniversityShalini Paruthi - UCLouvain Saint-Louis BrusselsHiren Muzumdar - Yeshiva UniversityDavid Gozal - University of ChicagoNina Hattiangadi Thomas - Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USAJanice Ware - College Station Medical CenterDean BeebeKaren Snyder - UCLouvain Saint-Louis BrusselsLisa Elden - University of PennsylvaniaRobert C. Sprecher - Case Western Reserve UniversityPaul Willging - Cincinnati Children's Hospital Medical CenterDwight Jones - Harvard University PressJohn P. Bent - Yeshiva UniversityTimothy Hoban - University of MichiganRonald D. Chervin - University of MichiganSusan S. Ellenberg - University of PennsylvaniaSusan Redline - Harvard University PressChildhood Adenotonsillectomy Trial
- Publication Details
- The New England journal of medicine, v 368(25), pp 2366-2376
- Publisher
- Massachusetts Medical Soc
- Number of pages
- 11
- Grant note
- Galleon Pharmaceuticals Guidepoint Global UL1RR024134; UL1RR024989 / NATIONAL CENTER FOR RESEARCH RESOURCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Research Resources (NCRR) Procter Gamble; Procter & Gamble OrbiMed Advisors Zansors National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA UL1TR000077 / NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS) U01HL083075; U01HL083129 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) Arena Pharmaceuticals HL083075; HL083129; UL1 RR024134; UL1 RR024989 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Epidemiology and Biostatistics
- Web of Science ID
- WOS:000320601700006
- Scopus ID
- 2-s2.0-84879121091
- Other Identifier
- 991021448025604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pediatrics